Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of Ketamine in rats

Journal of Pharmacological Sciences

Volumn 121, Issue 3, 2013, Pages 237-241

  Yoshizawa, Kazumi ^a   Mori, Tomohisa ^a   Ueno, Tamami ^a   Nishiwaki, Mizuki ^a   Shibasaki, Masahiro ^a   Shimizu, Norifumi ^a   Narita, Minoru ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

5 HT2 receptor; Atypical antipsychotic; Ketamine

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; KETAMINE; KETANSERIN; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SODIUM CHLORIDE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; DRUG MEGADOSE; IN VIVO STUDY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STIMULUS GENERALIZATION; STIMULUS RESPONSE;

EID: 84877267516     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12148SC     Document Type: Article

References (15)

1. Narita M, Yoshizawa K, Nomura M, Aoki K, Suzuki T. Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. Eur J Pharmacol. 2001;423:41-46. (Pubitemid 32595726)
2. Prommer EE. Ketamine for pain: an update of uses in palliative care. J Palliat Med. 2012;15:474-483.
3. Herbert Y, Meltzer HY, Horiguchi M, Massey BW. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl). 2011; 213:289-305.
4. Matsuzawa S, Suzuki T, Misawa M, Nagase H. Involvement of dopamine D1 and D2 receptors in the ethanol-Associated place preference in rats exposed to conditioned fear stress. Brain Res. 1999;835:298-305. (Pubitemid 29343793)
5. Narita M, Aoki K, Takagi Y, Yajima Y, Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience. 2003;119:767-775. (Pubitemid 36694803)
6. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. New York: Academic Press; 1998.
7. Ukai M, Mori E, Kameyama T. Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm. Pharmacol Biochem Behav. 1993;44: 907-911.
8. Yoshizawa K, Narita M, Mori T, Miyatake M, Isotani K, Tomiyasu S, et al. Role of dopamine D(2) and D(3) receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine. Addict Biol. 2012;17:949-955.
9. Philibin SD, Prus AJ, Pehrson AL, Porter JH. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology (Berl). 2005;180:49-56. (Pubitemid 40897070)
10. Rabin RA, Doat M, Winter JC. Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine. Int J Neuropsychopharmacol. 2000;3:333-338. (Pubitemid 32056628)
11. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87:1186-1193. (Pubitemid 28501183)
12. Dykstra LA, Preston KL, Bigelow GE. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology (Berl). 1997;130:14-27. (Pubitemid 27107781)
13. Krystal JH, D'Souza DC, Karper LP, Bennet A, Abi-Dargham A, Abi-Saab D, et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl). 1999;145:193-204. (Pubitemid 29362018)
14. Mori T, Yoshizawa K, Shibasaki M, Suzuki T. Discriminative stimulus effects of hallucinogenic drugs: a possible relation to reinforcing and aversive effects. J Pharmacol Sci. 2012;120: 70-76.
15. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009; 323:934-937.